164 related articles for article (PubMed ID: 38441894)
1. Rheumatoid Arthritis and Risk of Depression in South Korea.
Jeon KH; Han K; Jung J; Park CI; Eun Y; Shin DW; Kim H
JAMA Netw Open; 2024 Mar; 7(3):e241139. PubMed ID: 38441894
[TBL] [Abstract][Full Text] [Related]
2. Rheumatoid Arthritis and Risk of Parkinson Disease in Korea.
Kang J; Eun Y; Jang W; Cho MH; Han K; Jung J; Kim Y; Kim GT; Shin DW; Kim H
JAMA Neurol; 2023 Jun; 80(6):634-641. PubMed ID: 37126341
[TBL] [Abstract][Full Text] [Related]
3. Impact of Rheumatoid Arthritis and Seropositivity on the Risk of Non-Cystic Fibrosis Bronchiectasis.
Choi H; Han K; Jung JH; Park J; Kim BG; Yang B; Eun Y; Kim H; Shin DW; Lee H
Chest; 2024 Jun; 165(6):1330-1340. PubMed ID: 38184167
[TBL] [Abstract][Full Text] [Related]
4. Economic Burden and Treatment Patterns of Cycling between Conventional Synthetic Disease-modifying Antirheumatic Drugs Among Biologic-treated Patients with Rheumatoid Arthritis.
Betts KA; Griffith J; Ganguli A; Li N; Douglas K; Wu EQ
Clin Ther; 2016 May; 38(5):1205-16. PubMed ID: 27045991
[TBL] [Abstract][Full Text] [Related]
5. Development of an algorithm for identifying rheumatoid arthritis in the Korean National Health Insurance claims database.
Cho SK; Sung YK; Choi CB; Kwon JM; Lee EK; Bae SC
Rheumatol Int; 2013 Dec; 33(12):2985-92. PubMed ID: 23918169
[TBL] [Abstract][Full Text] [Related]
6. Association of acute myocardial infarction with seropositive rheumatoid arthritis in Korea: A nationwide longitudinal cohort study.
Lee JK; Kim H; Hong JB; Sheen SH; Han IB; Sohn S
J Clin Neurosci; 2020 Aug; 78():97-101. PubMed ID: 32620475
[TBL] [Abstract][Full Text] [Related]
7. Clinical management of seronegative and seropositive rheumatoid arthritis: A comparative study.
Choi S; Lee KH
PLoS One; 2018; 13(4):e0195550. PubMed ID: 29624625
[TBL] [Abstract][Full Text] [Related]
8. Increased risk of sudden sensory neural hearing loss in patients with rheumatoid arthritis: a longitudinal follow-up study using a national sample cohort.
Lee SY; Kong IG; Oh DJ; Choi HG
Clin Rheumatol; 2019 Mar; 38(3):683-689. PubMed ID: 30324407
[TBL] [Abstract][Full Text] [Related]
9. Validation of serostatus of rheumatoid arthritis using ICD-10 codes in administrative claims data.
Lee H; Sparks JA; Lee SB; Yoshida K; Landon JE; Kim SC
Pharmacoepidemiol Drug Saf; 2023 May; 32(5):586-591. PubMed ID: 36728737
[TBL] [Abstract][Full Text] [Related]
10. Incidence of Interstitial Lung Disease in Patients With Rheumatoid Arthritis Treated With Biologic and Targeted Synthetic Disease-Modifying Antirheumatic Drugs.
Baker MC; Liu Y; Lu R; Lin J; Melehani J; Robinson WH
JAMA Netw Open; 2023 Mar; 6(3):e233640. PubMed ID: 36939701
[TBL] [Abstract][Full Text] [Related]
11. Factors associated with the initiation of biologic disease-modifying antirheumatic drugs in Texas Medicaid patients with rheumatoid arthritis.
Kim G; Barner JC; Rascati K; Richards K
J Manag Care Spec Pharm; 2015 May; 21(5):401-7. PubMed ID: 25943001
[TBL] [Abstract][Full Text] [Related]
12. Impact of anti-rheumatic treatment on cardiovascular risk in Asian patients with rheumatoid arthritis.
Cho SK; Kim D; Won S; Lee J; Park B; Jang EJ; Bae SC; Sung YK
Semin Arthritis Rheum; 2018 Feb; 47(4):501-506. PubMed ID: 28863826
[TBL] [Abstract][Full Text] [Related]
13. Biologic disease-modifying anti-rheumatic drugs and the risk of non-vertebral osteoporotic fractures in patients with rheumatoid arthritis aged 50 years and over.
Roussy JP; Bessette L; Bernatsky S; Rahme E; Lachaine J
Osteoporos Int; 2013 Sep; 24(9):2483-92. PubMed ID: 23504029
[TBL] [Abstract][Full Text] [Related]
14. Mortality, disability, and healthcare expenditure of patients with seropositive rheumatoid arthritis in Korea: A nationwide population-based study.
Choi IA; Lee JS; Song YW; Lee EY
PLoS One; 2019; 14(1):e0210471. PubMed ID: 30620765
[TBL] [Abstract][Full Text] [Related]
15. Rheumatoid arthritis and neurodegenerative dementia: a nested case-control study and a follow-up study using a national sample cohort.
Min C; Bang WJ; Kim M; Oh DJ; Choi HG
Clin Rheumatol; 2020 Jan; 39(1):159-166. PubMed ID: 31523786
[TBL] [Abstract][Full Text] [Related]
16. Development of Open-Angle Glaucoma in Adults With Seropositive Rheumatoid Arthritis in Korea.
Kim SH; Jeong SH; Kim H; Park EC; Jang SY
JAMA Netw Open; 2022 Mar; 5(3):e223345. PubMed ID: 35311960
[TBL] [Abstract][Full Text] [Related]
17. Retrospective cohort study on risk of hearing loss in patients with rheumatoid arthritis using claims data.
Huang CM; Chen HJ; Huang PH; Tsay GJ; Lan JL; Sung FC
BMJ Open; 2018 Jan; 8(1):e018134. PubMed ID: 29306884
[TBL] [Abstract][Full Text] [Related]
18. Association between ischemic stroke and seropositive rheumatoid arthritis in Korea: A nationwide longitudinal cohort study.
Lee DH; Sheen SH; Lee DG; Jang JW; Lee DC; Shin SH; Han IB; Hong JB; Kim H; Sohn S
PLoS One; 2021; 16(5):e0251851. PubMed ID: 33999944
[TBL] [Abstract][Full Text] [Related]
19. Incident and recurrent herpes zoster for first-line bDMARD and tsDMARD users in seropositive rheumatoid arthritis patients: a nationwide cohort study.
Jeong S; Choi S; Park SM; Kim J; Ghang B; Lee EY
Arthritis Res Ther; 2022 Jul; 24(1):180. PubMed ID: 35902964
[TBL] [Abstract][Full Text] [Related]
20. Treatment persistence among patients with rheumatoid disease (RA, AS, PsA) treated with subcutaneous biologics in Germany.
Lyu R; Govoni M; Ding Q; Black CM; Kachroo S; Fan T; Ogbonnaya A; Donga P; Hill J; Makin C
Rheumatol Int; 2016 Jan; 36(1):143-53. PubMed ID: 26314368
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]